Q1 2026 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2026-05-14 · accession 0001420506-26-001003
$124.7M
Reported value
10
Positions
2026-03-31
Period end
The Brief · Blue Water Life Science Advisors, LP · Q1 2026
AI · grounded in 13F
Blue Water Life Science Advisors, LP established a new position in 10X GENOMICS INC TXG valued at $23.1M. The fund also opened a new position in BILLIONTOONE INC BLLN for $1.6M and increased share counts in CAREDX INC CDNA by 83.3% and TEMPUS AI INC TEM by 81%. Conversely, the fund closed its position in GRAIL INC GRAL, resulting in a $8.5M reduction.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 88025U109 | TXG | 10X GENOMICS INC | $23.1M | 18.6% | 1,090,000 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $22.4M | 17.9% | 242,247 | Common | SOLE |
| 14167L103 | CDNA | CAREDX INC | $16.2M | 13.0% | 935,000 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $14.0M | 11.2% | 1,010,145 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORP | $13.1M | 10.5% | 276,000 | Common | SOLE |
| 71535D106 | PSNL | PERSONALIS INC | $10.7M | 8.56% | 1,676,300 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $9.0M | 7.18% | 44,794 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $7.5M | 6.05% | 2,142,147 | Common | SOLE |
| 88023B103 | TEM | TEMPUS AI INC | $7.1M | 5.67% | 156,412 | Common | SOLE |
| 090168105 | BLLN | BILLIONTOONE INC | $1.6M | 1.27% | 20,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.